These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 24585456)
1. Re-analysis of the PREGNANT trial confirms that vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix. McKay LA; Holford TR; Bracken MB Ultrasound Obstet Gynecol; 2014 May; 43(5):596-7. PubMed ID: 24585456 [No Abstract] [Full Text] [Related]
2. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Hassan SS; Romero R; Vidyadhari D; Fusey S; Baxter JK; Khandelwal M; Vijayaraghavan J; Trivedi Y; Soma-Pillay P; Sambarey P; Dayal A; Potapov V; O'Brien J; Astakhov V; Yuzko O; Kinzler W; Dattel B; Sehdev H; Mazheika L; Manchulenko D; Gervasi MT; Sullivan L; Conde-Agudelo A; Phillips JA; Creasy GW; Ultrasound Obstet Gynecol; 2011 Jul; 38(1):18-31. PubMed ID: 21472815 [TBL] [Abstract][Full Text] [Related]
3. Vaginal progesterone in women with twin gestations complicated by short cervix: a retrospective cohort study. Brubaker SG; Pessel C; Zork N; Gyamfi-Bannerman C; Ananth CV BJOG; 2015 Apr; 122(5):712-8. PubMed ID: 25428801 [TBL] [Abstract][Full Text] [Related]
4. Universal cervical-length screening and vaginal progesterone prevents early preterm births, reduces neonatal morbidity and is cost saving: doing nothing is no longer an option. Campbell S Ultrasound Obstet Gynecol; 2011 Jul; 38(1):1-9. PubMed ID: 21713990 [No Abstract] [Full Text] [Related]
5. Treatment options and recommendations to reduce preterm births in women with short cervix. Slager J; Lynne S J Midwifery Womens Health; 2012 Jul; 57 Suppl 1():S12-8. PubMed ID: 22776244 [TBL] [Abstract][Full Text] [Related]
6. Vaginal Progesterone to Prevent Spontaneous Preterm Birth in Women With a Sonographic Short Cervix: The Story of the PREGNANT Trial. Romero R; Meyyazhagan A; Hassan SS; Creasy GW; Conde-Agudelo A Clin Obstet Gynecol; 2024 Jun; 67(2):433-457. PubMed ID: 38576410 [TBL] [Abstract][Full Text] [Related]
7. Vaginal progesterone for prevention of preterm labor in asymptomatic twin pregnancies with sonographic short cervix: a randomized clinical trial of efficacy and safety. El-Refaie W; Abdelhafez MS; Badawy A Arch Gynecol Obstet; 2016 Jan; 293(1):61-67. PubMed ID: 26044148 [TBL] [Abstract][Full Text] [Related]
8. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial. DeFranco EA; O'Brien JM; Adair CD; Lewis DF; Hall DR; Fusey S; Soma-Pillay P; Porter K; How H; Schakis R; Eller D; Trivedi Y; Vanburen G; Khandelwal M; Trofatter K; Vidyadhari D; Vijayaraghavan J; Weeks J; Dattel B; Newton E; Chazotte C; Valenzuela G; Calda P; Bsharat M; Creasy GW Ultrasound Obstet Gynecol; 2007 Oct; 30(5):697-705. PubMed ID: 17899571 [TBL] [Abstract][Full Text] [Related]
9. [Prevention of preterm birth with vaginal progesterone in women with preterm labor: which are the evidences?]. Martinez de Tejada B; Othenin-Girard V; Irion O Rev Med Suisse; 2015 Oct; 11(492):2004, 2006-8, 2010. PubMed ID: 26672179 [TBL] [Abstract][Full Text] [Related]
10. Short cervical length dilemma. Suhag A; Berghella V Obstet Gynecol Clin North Am; 2015 Jun; 42(2):241-54. PubMed ID: 26002164 [TBL] [Abstract][Full Text] [Related]
11. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. O'Brien JM; Adair CD; Lewis DF; Hall DR; Defranco EA; Fusey S; Soma-Pillay P; Porter K; How H; Schackis R; Eller D; Trivedi Y; Vanburen G; Khandelwal M; Trofatter K; Vidyadhari D; Vijayaraghavan J; Weeks J; Dattel B; Newton E; Chazotte C; Valenzuela G; Calda P; Bsharat M; Creasy GW Ultrasound Obstet Gynecol; 2007 Oct; 30(5):687-96. PubMed ID: 17899572 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of two treatment strategies for the prevention of preterm birth in women identified as at risk by ultrasound (PESAPRO Trial): study protocol for a randomized controlled trial. Cabrera-García L; Cruz-Melguizo S; Ruiz-Antorán B; Torres F; Velasco A; Martínez-Payo C; Avendaño-Solá C; Trials; 2015 Sep; 16():427. PubMed ID: 26407852 [TBL] [Abstract][Full Text] [Related]
13. Vaginal progesterone to reduce the rate of preterm birth and neonatal morbidity: a solution at last. Romero R Womens Health (Lond); 2011 Sep; 7(5):501-4. PubMed ID: 21879816 [No Abstract] [Full Text] [Related]
14. The effectiveness of vaginal progesterone to prevent preterm birth in singleton pregnant women with a short cervix at 18-32 weeks gestation. Wang X; Maerdan M; Xi J; Zhang M; Yang H; Shi C J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2412751. PubMed ID: 39406681 [TBL] [Abstract][Full Text] [Related]
15. Progesterone for preterm birth prevention. Ransom CE; Murtha AP Obstet Gynecol Clin North Am; 2012 Mar; 39(1):1-16, vii. PubMed ID: 22370103 [TBL] [Abstract][Full Text] [Related]
17. Preventing Preterm Birth with Progesterone in Women with a Short Cervical Length from a Low-Risk Population: A Multicenter Double-Blind Placebo-Controlled Randomized Trial. van Os MA; van der Ven AJ; Kleinrouweler CE; Schuit E; Kazemier BM; Verhoeven CJ; de Miranda E; van Wassenaer-Leemhuis AG; Sikkema JM; Woiski MD; Bossuyt PM; Pajkrt E; de Groot CJ; Mol BW; Haak MC Am J Perinatol; 2015 Aug; 32(10):993-1000. PubMed ID: 25738790 [TBL] [Abstract][Full Text] [Related]
19. 17-alpha-hydroxyprogesterone caproate versus vaginal progesterone suppository for the prevention of preterm birth in women with a sonographically short cervix: A randomized controlled trial. Pirjani R; Heidari R; Rahimi-Foroushani A; Bayesh S; Esmailzadeh A J Obstet Gynaecol Res; 2017 Jan; 43(1):57-64. PubMed ID: 27775195 [TBL] [Abstract][Full Text] [Related]
20. Universal cervical length screening in singleton gestations without a previous preterm birth: ten reasons why it should be implemented. Khalifeh A; Berghella V Am J Obstet Gynecol; 2016 May; 214(5):603.e1-5. PubMed ID: 26707072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]